Why “American Patients First” is likely to raise drug prices outside of the United States

Samankaltaisia teoksia

• Why “American Patients First” is likely to raise drug prices outside of the United States
  Tekijä: Monique Dabbous, et al.
  Julkaistu: (2019-01-01)
• President Trump’s prescription to reduce drug prices: from the campaign trail to American Patients First
  Tekijä: Dabbous, Monique, et al.
  Julkaistu: (2019)
• Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives
  Tekijä: Chachoua, Lylia, et al.
  Julkaistu: (2020)
• Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
  Tekijä: Jarosławski, Szymon, et al.
  Julkaistu: (2018)
• Patient-reported outcome claims in European and United States orphan drug approvals
  Tekijä: Jarosławski, Szymon, et al.
  Julkaistu: (2018)